跳至主要内容
临床试验/TCTR20230306002
TCTR20230306002已完成4 期

Clinical outcome of 1064-nm fractional picosecond laser for the treatment of post-mastectomy scar in transmen: A randomized controlled trial study

Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi hospital0 个研究点目标入组 22 人开始时间: 2023年3月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
N/A (No limit) 至 N/A (No limit)(—)
性别
Female

入选标准

  • Transmen wth symmetrical hypertrophic or atrophic mastectomy scars evaluated by a board-certified dermatologist were participated in the study.

排除标准

  • Exclusion criteria included 1) severe comorbidities, 2) co-occurring skin infection or inflammation or open wound or acne at the scar site, 3) history of immunodeficiency, skin cancer, coagulopathy, or recurrent herpes infection, 4) pregnancy or breastfeeding, and 5) history of scar treatment within 3 months prior to the study.

研究者

发起方
Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi hospital

相似试验